# Avient Corp: financial statements, quarterly

AVNT · NYSE · CIK 1122976 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avnt.md) · [Financials](/companies/avnt/financials.md) · [Filings](/companies/avnt/filings.md) · [Insiders](/companies/avnt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avnt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [754](/filings/0001122976-24-000066.md) | [719 d](/filings/0001122976-26-000039.md) | [829](/filings/0001122976-25-000030.md) | [850](/filings/0001122976-25-000053.md) | [815](/filings/0001122976-25-000088.md) | [747 d](/filings/0001122976-26-000039.md) | [827](/filings/0001122976-26-000094.md) | [867](/filings/0001122976-26-000126.md) | [807](/filings/0001122976-25-000088.md) | [761 d](/filings/0001122976-26-000039.md) | [847](/filings/0001122976-26-000094.md) | [917](/filings/0001122976-26-000126.md) |
| Cost of revenue | $m | [558](/filings/0001122976-24-000066.md) | [510 d](/filings/0001122976-26-000039.md) | [551](/filings/0001122976-25-000030.md) | [592](/filings/0001122976-25-000053.md) | [554](/filings/0001122976-25-000088.md) | [487 d](/filings/0001122976-26-000039.md) | [563](/filings/0001122976-26-000094.md) | [589](/filings/0001122976-26-000126.md) | [562](/filings/0001122976-25-000088.md) | [531 d](/filings/0001122976-26-000039.md) | [575](/filings/0001122976-26-000094.md) | [609](/filings/0001122976-26-000126.md) |
| Gross profit | $m | [195](/filings/0001122976-24-000066.md) | [209 d](/filings/0001122976-26-000039.md) | [278](/filings/0001122976-25-000030.md) | [258](/filings/0001122976-25-000053.md) | [261](/filings/0001122976-25-000088.md) | [260 d](/filings/0001122976-26-000039.md) | [263](/filings/0001122976-26-000094.md) | [278](/filings/0001122976-26-000126.md) | [245](/filings/0001122976-25-000088.md) | [230 d](/filings/0001122976-26-000039.md) | [273](/filings/0001122976-26-000094.md) | [308](/filings/0001122976-26-000126.md) |
| Selling, general and administrative | $m | [161](/filings/0001122976-24-000066.md) | [166 d](/filings/0001122976-26-000039.md) | [184](/filings/0001122976-25-000030.md) | [185](/filings/0001122976-25-000053.md) | [184](/filings/0001122976-25-000088.md) | [174 d](/filings/0001122976-26-000039.md) | [263](/filings/0001122976-26-000094.md) | [182](/filings/0001122976-26-000126.md) | [178](/filings/0001122976-25-000088.md) | [190 d](/filings/0001122976-26-000039.md) | [177](/filings/0001122976-26-000094.md) | [195](/filings/0001122976-26-000126.md) |
| Operating income | $m | [34.3](/filings/0001122976-24-000066.md) | [43.1 d](/filings/0001122976-26-000039.md) | [94.0](/filings/0001122976-25-000030.md) | [72.5](/filings/0001122976-25-000053.md) | [77.2](/filings/0001122976-25-000088.md) | [85.6 d](/filings/0001122976-26-000039.md) | [0.7](/filings/0001122976-26-000094.md) | [96.1](/filings/0001122976-26-000126.md) | [67.1](/filings/0001122976-25-000088.md) | [39.6 d](/filings/0001122976-26-000039.md) | [95.8](/filings/0001122976-26-000094.md) | [112](/filings/0001122976-26-000126.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.1)](/filings/0001122976-24-000066.md) | [(7.0) d](/filings/0001122976-26-000039.md) | [16.8](/filings/0001122976-25-000030.md) | [11.2](/filings/0001122976-25-000053.md) | [11.3](/filings/0001122976-25-000088.md) | [14.8 d](/filings/0001122976-26-000039.md) | [(6.7)](/filings/0001122976-26-000094.md) | [17.4](/filings/0001122976-26-000126.md) | [10.1](/filings/0001122976-25-000088.md) | [7.3 d](/filings/0001122976-26-000039.md) | [16.5](/filings/0001122976-26-000094.md) | [23.4](/filings/0001122976-26-000126.md) |
| Net income | $m | [5.1](/filings/0001122976-24-000066.md) | [28.6 d](/filings/0001122976-26-000039.md) | [49.4](/filings/0001122976-25-000030.md) | [33.6](/filings/0001122976-25-000053.md) | [38.2](/filings/0001122976-25-000088.md) | [48.3 d](/filings/0001122976-26-000039.md) | [(20.2)](/filings/0001122976-26-000094.md) | [52.6](/filings/0001122976-26-000126.md) | [32.6](/filings/0001122976-25-000088.md) | [16.9 d](/filings/0001122976-26-000039.md) | [55.7](/filings/0001122976-26-000094.md) | [64.8](/filings/0001122976-26-000126.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001122976-24-000066.md) | not reported | [0.54](/filings/0001122976-25-000030.md) | [0.36](/filings/0001122976-25-000053.md) | [0.41](/filings/0001122976-25-000088.md) | not reported | [(0.22)](/filings/0001122976-26-000094.md) | [0.57](/filings/0001122976-26-000126.md) | [0.36](/filings/0001122976-25-000088.md) | not reported | [0.61](/filings/0001122976-26-000094.md) | [0.70](/filings/0001122976-26-000126.md) |
| Basic EPS | $ per share | [0.06](/filings/0001122976-24-000066.md) | not reported | [0.54](/filings/0001122976-25-000030.md) | [0.37](/filings/0001122976-25-000053.md) | [0.42](/filings/0001122976-25-000088.md) | not reported | [(0.22)](/filings/0001122976-26-000094.md) | [0.57](/filings/0001122976-26-000126.md) | [0.36](/filings/0001122976-25-000088.md) | not reported | [0.61](/filings/0001122976-26-000094.md) | [0.71](/filings/0001122976-26-000126.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [1,364](/filings/0001122976-23-000056.md) | [1,408](/filings/0001122976-25-000008.md) | [1,391](/filings/0001122976-24-000033.md) | [1,459](/filings/0001122976-24-000057.md) | [1,457](/filings/0001122976-24-000066.md) | [1,422](/filings/0001122976-26-000039.md) | [1,430](/filings/0001122976-25-000030.md) | [1,494](/filings/0001122976-25-000053.md) | [1,424](/filings/0001122976-25-000088.md) | [1,401](/filings/0001122976-26-000126.md) | [1,424](/filings/0001122976-26-000094.md) | [1,533](/filings/0001122976-26-000126.md) |
| Total assets | $m | [5,790](/filings/0001122976-23-000056.md) | [5,969](/filings/0001122976-25-000008.md) | [5,876](/filings/0001122976-24-000033.md) | [5,908](/filings/0001122976-24-000057.md) | [6,047](/filings/0001122976-24-000066.md) | [5,811](/filings/0001122976-26-000039.md) | [5,811](/filings/0001122976-25-000030.md) | [6,133](/filings/0001122976-25-000053.md) | [6,056](/filings/0001122976-25-000088.md) | [6,026](/filings/0001122976-26-000126.md) | [5,945](/filings/0001122976-26-000094.md) | [6,005](/filings/0001122976-26-000126.md) |
| Current liabilities | $m | [727](/filings/0001122976-23-000056.md) | [774](/filings/0001122976-25-000008.md) | [732](/filings/0001122976-24-000033.md) | [1,498](/filings/0001122976-24-000057.md) | [895](/filings/0001122976-24-000066.md) | [756](/filings/0001122976-26-000039.md) | [698](/filings/0001122976-25-000030.md) | [737](/filings/0001122976-25-000053.md) | [702](/filings/0001122976-25-000088.md) | [846](/filings/0001122976-26-000126.md) | [803](/filings/0001122976-26-000094.md) | [807](/filings/0001122976-26-000126.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [2,071](/filings/0001122976-23-000056.md) | [2,071](/filings/0001122976-25-000008.md) | [2,069](/filings/0001122976-24-000033.md) | [1,421](/filings/0001122976-24-000057.md) | [2,060](/filings/0001122976-24-000066.md) | [2,059](/filings/0001122976-26-000039.md) | [2,061](/filings/0001122976-25-000030.md) | [2,020](/filings/0001122976-25-000053.md) | [1,971](/filings/0001122976-25-000088.md) | [1,923](/filings/0001122976-26-000126.md) | [1,924](/filings/0001122976-26-000094.md) | [1,875](/filings/0001122976-26-000126.md) |
| Current portion of debt | $m | [9.5](/filings/0001122976-23-000056.md) | [9.5](/filings/0001122976-25-000008.md) | [9.6](/filings/0001122976-24-000033.md) | [658](/filings/0001122976-24-000057.md) | [7.8](/filings/0001122976-24-000066.md) | [7.7](/filings/0001122976-26-000039.md) | [7.8](/filings/0001122976-25-000030.md) | [0.5](/filings/0001122976-25-000053.md) | [0.5](/filings/0001122976-25-000088.md) | [0.5](/filings/0001122976-26-000126.md) | [0.5](/filings/0001122976-26-000094.md) | [0.5](/filings/0001122976-26-000126.md) |
| Shareholders' equity | $m | [2,277](/filings/0001122976-23-000056.md) | [2,319](/filings/0001122976-25-000008.md) | [2,321](/filings/0001122976-24-000033.md) | [2,318](/filings/0001122976-24-000057.md) | [2,363](/filings/0001122976-24-000066.md) | [2,314](/filings/0001122976-26-000039.md) | [2,298](/filings/0001122976-25-000030.md) | [2,358](/filings/0001122976-25-000053.md) | [2,373](/filings/0001122976-25-000088.md) | [2,374](/filings/0001122976-26-000126.md) | [2,406](/filings/0001122976-26-000094.md) | [2,437](/filings/0001122976-26-000126.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [71.8 d](/filings/0001122976-24-000066.md) | [155 d](/filings/0001122976-26-000039.md) | [(42.8)](/filings/0001122976-25-000030.md) | [106 d](/filings/0001122976-25-000053.md) | [71.1 d](/filings/0001122976-25-000088.md) | [123 d](/filings/0001122976-26-000039.md) | [(51.1)](/filings/0001122976-26-000094.md) | [113 d](/filings/0001122976-26-000126.md) | [72.1 d](/filings/0001122976-25-000088.md) | [168 d](/filings/0001122976-26-000039.md) | [(34.5)](/filings/0001122976-26-000094.md) | [93.8 d](/filings/0001122976-26-000126.md) |
| Capital expenditure | $m | [29.1 d](/filings/0001122976-24-000066.md) | [44.4 d](/filings/0001122976-26-000039.md) | [24.4](/filings/0001122976-25-000030.md) | [31.4 d](/filings/0001122976-25-000053.md) | [25.0 d](/filings/0001122976-25-000088.md) | [41.1 d](/filings/0001122976-26-000039.md) | [12.5](/filings/0001122976-26-000094.md) | [27.0 d](/filings/0001122976-26-000126.md) | [24.7 d](/filings/0001122976-25-000088.md) | [42.4 d](/filings/0001122976-26-000039.md) | [19.0](/filings/0001122976-26-000094.md) | [22.3 d](/filings/0001122976-26-000126.md) |
| Dividends paid | $m | [22.6 d](/filings/0001122976-24-000066.md) | [22.6 d](/filings/0001122976-26-000039.md) | [23.5](/filings/0001122976-25-000030.md) | [23.5 d](/filings/0001122976-25-000053.md) | [23.5 d](/filings/0001122976-25-000088.md) | [23.5 d](/filings/0001122976-26-000039.md) | [24.7](/filings/0001122976-26-000094.md) | [24.7 d](/filings/0001122976-26-000126.md) | [24.7 d](/filings/0001122976-25-000088.md) | [24.7 d](/filings/0001122976-26-000039.md) | [25.2](/filings/0001122976-26-000094.md) | [25.2 d](/filings/0001122976-26-000126.md) |
| Share repurchases | $m | [0.0 d](/filings/0001122976-23-000056.md) | [0.0 d](/filings/0001122976-25-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [90.9](/filings/0001122976-23-000056.md) | [91.8](/filings/0001122976-24-000033.md) | [91.9](/filings/0001122976-24-000057.md) | [91.9](/filings/0001122976-24-000066.md) | [92.0](/filings/0001122976-25-000030.md) | [92.2](/filings/0001122976-25-000053.md) | [92.3](/filings/0001122976-25-000088.md) | [91.5](/filings/0001122976-26-000094.md) | [91.8](/filings/0001122976-26-000126.md) | [91.8](/filings/0001122976-25-000088.md) | [91.9](/filings/0001122976-26-000094.md) | [92.2](/filings/0001122976-26-000126.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,719,550 at 2026-06-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001122976-26-000126.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.